Viewing Study NCT06790602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-05-29 @ 10:40 PM
Study NCT ID: NCT06790602
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-04
First Post: 2025-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Sponsor: University of California, San Diego
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma (mPDAC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cemiplimab View
None gemcitabine View
None immune checkpoint inhibitors View
None pancreatic ductal adenocarcinoma View
None SWI/SNF View
None combination therapy View
None PDAC View
None Phase 2 View
None metastatic View